Lataa...
NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma
Background: Novel immune therapies targeting tumor specific antigens are being developed. Our purpose was to determine expression of the cancer testes antigen NY-ESO-1 in renal cell carcinoma (RCC), as NY-ESO-1 targeting approaches, particularly adoptive cell therapy, have not been evaluated in this...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Impact Journals LLC
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4170640/ https://ncbi.nlm.nih.gov/pubmed/24970819 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|